Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Lear

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Journal of the Royal Society of Medicine|July 1, 1997
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patientsJ T Lear, B B Tan, A G Smith, et al.
The Journal of Investigative Dermatology|April 1, 1997
Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interactionJ T Lear, A G Smith, B Bowers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 1999
Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotypeS Ramachandran, J T Lear, H Ramsay, et al.
Carcinogenesis|August 1, 1997
Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinomaJ T Lear, A G Smith, A H Heagerty, et al.
Pharmacogenetics|May 8, 2001
Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotypeS Ramachandran, A A Fryer, A G Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanomaP E Hutchinson, J E Osborne, J T Lear, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2011
Photodynamic therapy for actinic keratosis in organ transplant patientsN Basset-Seguin, K Baumann Conzett, M J P Gerritsen, et al.
Pharmacogenetics|September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumoursS Ramachandran, P R Hoban, F Ichii-Jones, et al.
Annals of Human Genetics|December 16, 2004
Susceptibility to basal cell carcinoma: associations with PTCH polymorphismsR C Strange, N El-Genidy, S Ramachandran, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Journal of the Royal Society of Medicine|July 1, 1997
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patientsJ T Lear, B B Tan, A G Smith, et al.
The Journal of Investigative Dermatology|April 1, 1997
Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interactionJ T Lear, A G Smith, B Bowers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 1999
Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotypeS Ramachandran, J T Lear, H Ramsay, et al.
Carcinogenesis|August 1, 1997
Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinomaJ T Lear, A G Smith, A H Heagerty, et al.
Pharmacogenetics|May 8, 2001
Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotypeS Ramachandran, A A Fryer, A G Smith, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanomaP E Hutchinson, J E Osborne, J T Lear, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2011
Photodynamic therapy for actinic keratosis in organ transplant patientsN Basset-Seguin, K Baumann Conzett, M J P Gerritsen, et al.
Pharmacogenetics|September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumoursS Ramachandran, P R Hoban, F Ichii-Jones, et al.
Annals of Human Genetics|December 16, 2004
Susceptibility to basal cell carcinoma: associations with PTCH polymorphismsR C Strange, N El-Genidy, S Ramachandran, et al.
Pageof 12